Related Experiment Video

Updated: Jun 24, 2025

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
12:18

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

Published on: February 9, 2011

23.0K

Necrotizing pneumonia associated with macrolide-resistant Mycoplasma in a child

Guodong Ding1, Lan Yang2, Changli Xu2

  • 1Department of Pediatrics, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Pediatric Pulmonology
|June 5, 2024
PubMed

Insights

Necrotizing pneumonia in a child was caused by macrolide-resistant Mycoplasma pneumoniae. This resistance complicates treatment, necessitating extended antibiotic courses and additional therapies for recovery.

Area of Science:

  • Pediatric Pulmonology
  • Infectious Diseases
  • Microbiology

Background:

  • Mycoplasma pneumoniae is a common cause of respiratory infections in children.
  • Macrolide antibiotics are the standard treatment for M. pneumoniae infections.
  • Emergence of macrolide resistance in M. pneumoniae poses a therapeutic challenge.

Observation:

  • A pediatric case presented with necrotizing pneumonia, an unusual manifestation.
  • The causative agent was identified as macrolide-resistant Mycoplasma pneumoniae.
  • The resistance did not appear to increase the pathogen's virulence.

Findings:

  • Macrolide resistance in M. pneumoniae complicates clinical management.
  • Treatment requires extended antibiotic therapy.
  • Addition of a second-line antibiotic agent and an immunomodulator is necessary for clinical improvement.

Implications:

  • This case highlights the clinical significance of macrolide-resistant M. pneumoniae in pediatric populations.
  • Effective management strategies involve multi-drug approaches.
  • Further research into resistance mechanisms and alternative treatments is warranted.
Keywords:
Mycoplasma pneumoniaechildrenmacrolide‐resistantnecrotizing pneumonia

More Related Videos

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae06:04

Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae

Published on: February 24, 2023

2.4K
Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling08:25

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling

Published on: April 7, 2015

9.0K

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
221
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
200
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
322
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
255